Ovid Therapeutics Other Operating Expenses (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.655 +0.04 (+2.16%) USD | NASDAQ | Feb 26, 16:00

1.62 -0.04 (-2.11%) After-Hours: 19:32

View Other Operating Expenses (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--